Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03300674 · ClinicalTrials.gov registry record · Phase 4
Intravenous Lidocaine Randomized Comparative Effectiveness Trial
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 154
- Enrollment target
NCT03300674 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 154 participants.
The verdict
NCT03300674, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 154 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, emergency department based, comparative effectiveness study of two medication for acute abdominal pain: intravenous lidocaine and intravenous hydromorphone. Patients will be enrolled during an emergency department visit and followed throughout their emergency department course and then by telephone 7 days later.
Interventions
- DRUG Lidocaine
- DRUG Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2018-01-10 |
| Est. Completion | 2018-08-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03300674
The ClinicalTrials.gov registry entry for NCT03300674 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine is the first listed.
NCT03300674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03300674 about?
NCT03300674 is a clinical study titled "Intravenous Lidocaine Randomized Comparative Effectiveness Trial". This is a randomized, double-blind, emergency department based, comparative effectiveness study of two medication for acute abdominal pain: intravenous lidocaine and intravenous hydromorphone. Patients will be enrolled during an emergency department visit and followed throughout their emergency depa...
What is the current status of trial NCT03300674?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 154 participants. The study started on 2018-01-10. Estimated completion is 2018-08-28.
What interventions are being tested in trial NCT03300674?
The interventions under investigation include: Lidocaine (DRUG), Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT03300674?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.